Publications

Fitzgerald L, Wikoff DS. 2014. Persistent organic pollutants. In: Wexler P (Ed.), Encyclopedia of Toxicology, 3rd edition, vol 3. Elsevier, Inc., Academic Press, pp. 820-825.

Wu C, Fortier KJ, LaPensee K, Fan W, Mitchell M, Cyr PL, Jensen IS. A US hospital economic impact model for oritavancin in ABSSSI patients with risk of MRSA infections. Abstract PSS10, ISPOR 17th Annual European Congress 2014.

Sane RS, Steinmann GG, Huang Q, Li Y, Podila L, Mease K, Olson S, Taub ME, et al. 2014. Mechanisms underlying benign and reversible unconjugated hyperbilirubinemia observed with faldaprevir administration in HCV patients. J Pharmacol Exp Ther 351(2):403–412; doi: 10.1124/jpet.114.218081. PMID: 25204339.

Cohen SS, Sadoff MM, Jiang X, Fryzek JP, Garabrant DH. 2014. A review and meta-analysis of cancer risks in relation to Portland cement exposure. Occup Environ Med 71(11):796-802; doi: 10.1136/oemed-2014-102193. PMID: 25143515.

Tran T, Racz L, Grimaila MR, Miller M, Harper WF Jr. 2014. Comparison of continuous versus pulsed ultraviolet light emitting diode use for the inactivation of Bacillus globigii spores. Water Sci Technol 70(9):1473–1480; doi: 10.2166/wst.2014.395. PMID: 25401310.

Proctor DM, Suh M, Campleman SL, Thompson CM. 2014. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures. Toxicology 325(Nov):160-179; doi: 10.1016/j.tox.2014.08.009. PMID: 25174529.

Haws LC, Thompson C, Perry C, White M, Fitzgerald L, Borghoff S, Wikoff D. Development of non-cancer based toxicity factors and daily dose estimates for TBBPA. Presented at Society of Toxicology 53rd Annual Meeting, Phoenix, AZ, March 2014.

Erichsen R, Kelsh MA, Oliner KS, Nielsen KB, Frøslev T, Lænkholm AV, et al. Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Taipei, Taiwan, October 28–30, 2014.

Meddings J, Reichert H, McMahon LF. 2014. Challenges and proposed improvements for reviewing symptoms and catheter use to identify National Healthcare Safety Network catheter-associated urinary tract infections. Am J Infect Cont 42(10):S236-S241; doi: 10.1016/j.ajic.2014.05.024. PMID: 25239716.

Meddings J, Saint S, Krein S, Gaies E, Reichert H, Hickner A, McNamara S, Mody L. Systematic review of interventions to reduce catheter-associated urinary tract infection in the long-term care setting. Presented at ID Week, Philadelphia, PA, October 2014.

Maier A, Vincent MJ, Gadagbui B, Patterson J, Beckett W, Dalton P, et al. 2014. Integrating asthma hazard characterization methods for consumer products. Regul Toxicol Pharmacol 70(1):37–45; doi: 10.1016/j.yrtph.2014.06.009. PMID: 24937810.

Greene T, Kiyoshi-Teo H, Reichert H, Krein S, Saint S. 2014. Urinary catheter indications in the United States: Results from a national survey of acute care hospitals. Infect Contr Hosp Epidemiol 35(Sup 3):S96-S98; doi: 10.1086/677823. PMID: 25222904.

Johnson GE, Soeteman-Hernandez, Gollapudi BB, Bodger OG, Dearfield KL, RH Heflich,…, Thompson CM, Abraham L, et al. 2014. Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment. Environ Molec Mutagen 55(8):609-623; doi: 10.1002/em.21870/em.21870. PMID: 24801602.

Henderson R, Verougstraete V, Anderson K, Arbildua JJ, Brock TO, Brouwers T, Cappellini D, Delbeke K, et al. 2014. Interlaboratory validation of bioaccessibility testing for metals. Regul Toxicol Pharmacol 70(1):170-181; doi: 10.1016/j.yrtph.2014.06.02. PMID: 24979734.

Mahadevan B, Thorsrud BA, Brorby GP, Ferguson HE. 2014. A 3-week dietary safety study of octenyl succinic anhydride (OSA)-modified starch in neonatal farm piglets. Food Chem Toxicol 72(Oct):83-89; doi: 10.1016/j.fct.2014.07.009. PMID: 25019245.

LaPlaca SB, Tufford DL. Assessing the spatial and temporal aspects of buffer capacity in Lake Wateree, SC. Poster presentation at the South Carolina Water Resources Conference, Columbia, SC, October 2014

Kirman CR, Proctor D, Suh M, Thompson CM, Harris MA, Haws LC, Hays SM. Variation analysis of PBPK model parameters for describing the delivery of Cr(VI) to the small intestines of humans. Presented at Society of Toxicology 53rd Annual Meeting, Phoenix, AZ, March 2014.

Christian WV, Oliver LD, Paustenbach DJ, Kreider ML, Finley BL. 2014. Toxicology-based cancer causation analysis of CoCr-containing hip implants: A quantitative assessment of genotoxicity and tumorigenicity studies. J Appl Toxicol 34(9):939–967; doi: 10.1002/jat.3039. PMID: 25080401.

Vivanco S. Protecting the movie industry from lead generated by pyrotechnic effects. Presentation to AMEC Technical Summit, 2014.

Wirbisky SE, Weber GJ, Lee JW, Cannon JR, Freeman JL. 2014. Novel dose-dependent alterations in excitatory GABA during embryonic development associated with lead (Pb) neurotoxicity. Toxicol Lett 229(1):1–8; doi: 10.1016/j.toxlet.2014.05.016. PMID: 24875535.